Quoin Pharmaceuticals - 10 Year Stock Price History | QNRX

Historical daily share price chart and data for Quoin Pharmaceuticals since 2016 adjusted for splits and dividends. The latest closing stock price for Quoin Pharmaceuticals as of January 20, 2026 is 10.45.

The all-time high Quoin Pharmaceuticals stock closing price was 1000000.00 on March 27, 2017.
The Quoin Pharmaceuticals 52-week high stock price is 41.80, which is 300% above the current share price.
The Quoin Pharmaceuticals 52-week low stock price is 5.01, which is 52.1% below the current share price.
The average Quoin Pharmaceuticals stock price for the last 52 weeks is 10.03.

Quoin Pharmaceuticals Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	12.2040	14.0800	14.0800	10.2700	10.4500	-27.58%
2025	10.5340	23.5200	24.5000	5.2800	14.4300	-36.67%
2024	41.4013	169.2250	169.2250	16.8000	22.7850	-86.73%
2023	263.2203	613.2000	1062.6000	131.9500	171.6750	-71.21%
2022	3540.8870	11235.0000	11235.0000	476.7000	596.4000	-93.76%
2021	68034.9980	48300.0000	140700.0000	9397.5000	9555.0000	-78.94%
2020	51604.1383	50190.0000	85890.0000	26040.0000	45360.0000	-2.70%
2019	89969.2500	242550.0000	320250.0000	43050.0000	46620.0000	-78.86%
2018	644317.8287	813750.0000	1000000.0000	220500.0000	220500.0000	-70.00%
2017	778482.0120	322140.0000	1000000.0000	322140.0000	735000.0000	126.54%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.009B	$0.000B
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Quoin Pharmaceuticals, formerly known as Cellect Biotechnology Ltd., is based in Tel Aviv.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$85.303B	32.40
Zoetis (ZTS)	United States	$54.932B	19.66
Takeda Pharmaceutical (TAK)	Japan	$51.421B	10.49
Daiichi Sankyo, - (DSNKY)	Japan	$39.630B	19.74
BeOne Medicines - (ONC)	Switzerland	$37.087B	196.62
Sandoz Group AG (SDZNY)	Switzerland	$33.939B	0.00
United Therapeutics (UTHR)	United States	$20.018B	17.62
Merck (MKKGY)	Germany	$19.496B	12.02
Shionogi (SGIOY)	Japan	$15.261B	14.02
Neurocrine Biosciences (NBIX)	United States	$13.200B	31.67
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$13.109B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.364B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.394B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.236B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Grifols, S.A (GRFS)	Spain	$6.112B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.981B	33.47
Crinetics Pharmaceuticals (CRNX)	United States	$5.313B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.216B	20.01
Indivior (INDV)	United States	$4.068B	16.60
Corcept Therapeutics (CORT)	United States	$3.653B	39.47
NewAmsterdam Pharma (NAMS)	Netherlands	$3.589B	0.00
Hypermarcas (HYPMY)	Brazil	$3.047B	20.91
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.984B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.790B	8.90
Ocular Therapeutix (OCUL)	United States	$2.401B	0.00
Dyne Therapeutics (DYN)	United States	$2.386B	0.00
Soleno Therapeutics (SLNO)	United States	$2.282B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.958B	23.20
Harrow (HROW)	United States	$1.774B	108.86
Guardian Pharmacy Services (GRDN)	United States	$1.712B	32.96
Ardelyx (ARDX)	United States	$1.640B	0.00
Oruka Therapeutics (ORKA)	United States	$1.617B	0.00
Enliven Therapeutics (ELVN)	United States	$1.585B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.570B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.441B	7.14
BioCryst Pharmaceuticals (BCRX)	United States	$1.404B	83.25
Evotec AG (EVO)	Germany	$1.282B	0.00
Relay Therapeutics (RLAY)	United States	$1.274B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.248B	0.00
Savara (SVRA)	United States	$1.184B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.051B	0.00
Theravance Biopharma (TBPH)	United States	$1.014B	42.57
Aktis Oncology (AKTS)	United States	$1.000B	0.00
Cronos Group (CRON)	Canada	$0.967B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Nektar Therapeutics (NKTR)	United States	$0.766B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.738B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Esperion Therapeutics (ESPR)	United States	$0.727B	0.00
ProKidney (PROK)	United States	$0.689B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.680B	6.07
Bioventus (BVS)	United States	$0.656B	13.44
Lexeo Therapeutics (LXEO)	United States	$0.539B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.506B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.503B	0.00
Organogenesis (ORGO)	United States	$0.481B	0.00
Siga Technologies (SIGA)	United States	$0.471B	6.45
Altimmune (ALT)	United States	$0.442B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.431B	0.00
Nature's Sunshine Products (NATR)	United States	$0.421B	25.07
Aquestive Therapeutics (AQST)	United States	$0.404B	0.00
USANA Health Sciences (USNA)	United States	$0.401B	11.19
Cybin (HELP)	Canada	$0.386B	0.00
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.310B	0.00
Profound Medical (PROF)	Canada	$0.298B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.284B	0.00
Avalo Therapeutics (AVTX)	United States	$0.279B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.279B	0.00
Relmada Therapeutics (RLMD)	United States	$0.274B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Fractyl Health (GUTS)	United States	$0.262B	0.00
Larimar Therapeutics (LRMR)	United States	$0.259B	0.00
Protara Therapeutics (TARA)	United States	$0.259B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.238B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.223B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.209B	0.00
MediWound (MDWD)	Israel	$0.209B	0.00
Galectin Therapeutics (GALT)	United States	$0.196B	0.00
Minerva Neurosciences (NERV)	United States	$0.193B	0.00
Century Therapeutics (IPSC)	United States	$0.190B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
VAXART, INC (VXRT)	United States	$0.169B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Context Therapeutics (CNTX)	United States	$0.132B	0.00
Incannex Healthcare (IXHL)	Australia	$0.131B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.116B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.114B	0.00
Pyxis Oncology (PYXS)	United States	$0.110B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.105B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.41
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Korro Bio (KRRO)	United States	$0.083B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.12
PolyPid (PYPD)	Israel	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.067B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.048B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.020B	0.00
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Vyome Holdings (HIND)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00